Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1245803.RAMTGbwHB6rUuY-mVfo4LbOrJcRfcXOYVr8xFPTgcJLG0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1245803.RAMTGbwHB6rUuY-mVfo4LbOrJcRfcXOYVr8xFPTgcJLG0130_assertion type Assertion NP1245803.RAMTGbwHB6rUuY-mVfo4LbOrJcRfcXOYVr8xFPTgcJLG0130_head.
- NP1245803.RAMTGbwHB6rUuY-mVfo4LbOrJcRfcXOYVr8xFPTgcJLG0130_assertion description "[Normal ovarian tissue exhibited very little or no AEG?1 immunoreactivity, whereas high expression levels of AEG?1 were detected in 12.7% of cystadenomas, 30.0% of borderline tumors, and 71.2% of ovarian carcinomas, respectively, as determined by immunohistochemistry.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245803.RAMTGbwHB6rUuY-mVfo4LbOrJcRfcXOYVr8xFPTgcJLG0130_provenance.
- NP1245803.RAMTGbwHB6rUuY-mVfo4LbOrJcRfcXOYVr8xFPTgcJLG0130_assertion evidence source_evidence_literature NP1245803.RAMTGbwHB6rUuY-mVfo4LbOrJcRfcXOYVr8xFPTgcJLG0130_provenance.
- NP1245803.RAMTGbwHB6rUuY-mVfo4LbOrJcRfcXOYVr8xFPTgcJLG0130_assertion SIO_000772 25483832 NP1245803.RAMTGbwHB6rUuY-mVfo4LbOrJcRfcXOYVr8xFPTgcJLG0130_provenance.
- NP1245803.RAMTGbwHB6rUuY-mVfo4LbOrJcRfcXOYVr8xFPTgcJLG0130_assertion wasDerivedFrom befree-2016 NP1245803.RAMTGbwHB6rUuY-mVfo4LbOrJcRfcXOYVr8xFPTgcJLG0130_provenance.
- NP1245803.RAMTGbwHB6rUuY-mVfo4LbOrJcRfcXOYVr8xFPTgcJLG0130_assertion wasGeneratedBy ECO_0000203 NP1245803.RAMTGbwHB6rUuY-mVfo4LbOrJcRfcXOYVr8xFPTgcJLG0130_provenance.